Ridgefield, CT, United States of America

Patricia Giblin

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Patricia Giblin: Innovator in Biopharmaceuticals

Introduction

Patricia Giblin is a notable inventor based in Ridgefield, CT (US), recognized for her contributions to the field of biopharmaceuticals. With a total of three patents to her name, she has made significant strides in developing compounds that target specific inflammatory pathways.

Latest Patents

Among her latest patents is a groundbreaking invention related to compounds targeting IL-23A and TNF-alpha. This patent discloses compounds that are specific for IL-23A and TNF-alpha, along with compositions that comprise these compounds and methods for their use. Additionally, the patent includes nucleic acids, cells, and methods of production related to these innovative compounds and compositions.

Career Highlights

Throughout her career, Patricia has worked with prominent companies in the biopharmaceutical industry, including Boehringer Ingelheim International GmbH and Macrogenics, Inc. Her work has contributed to advancements in therapeutic approaches for various diseases.

Collaborations

Patricia has collaborated with several professionals in her field, including Rachel Rebecca Barrett and Leslie Sydnor Johnson. These collaborations have further enhanced her research and development efforts.

Conclusion

Patricia Giblin's innovative work in targeting IL-23A and TNF-alpha showcases her commitment to advancing biopharmaceutical research. Her contributions continue to impact the field positively, paving the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…